We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+0.48%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+549.41%
AUM
$175B
AUM Growth
+$210M
Cap. Flow
+$589M
Cap. Flow %
0.34%
Top 10 Hldgs %
15.16%
Holding
4,062
New
109
Increased
2,831
Reduced
660
Closed
104

Top Buys

Rank Stock Value
1
ES icon
Eversource Energy
ES
+$124M
2
EQIX icon
Equinix
EQIX
+$116M
3
QRVO icon
Qorvo
QRVO
+$92.4M
4
RAI
Reynolds American Inc
RAI
+$61.4M
5
ABBV icon
AbbVie
ABBV
+$58.8M

Sector Composition

Rank Sector Weight
1 Financials 15.29%
2 Healthcare 14.9%
3 Technology 14.58%
4 Industrials 10.38%
5 Consumer Discretionary 9.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPRS
3226
DELISTED
EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
$427K ﹤0.01%
74,947
+10,708
+17% +$73.1K
CNXR
3227
DELISTED
Connecture, Inc.
CNXR
$426K ﹤0.01%
40,383
+14,004
+53% +$155K
CVV icon
3228
CVD Equipment Corp
CVV
$56.8M
$425K ﹤0.01%
38,154
SPRT
3229
DELISTED
support.com, Inc.
SPRT
$424K ﹤0.01%
100,357
+61
+0.1% +$279
ATNY
3230
DELISTED
API TECHNOLOGIES CORP. COMMON STOCK
ATNY
$423K ﹤0.01%
168,640
+190
+0.1% +$409
AER icon
3231
AerCap
AER
$23.8B
$421K ﹤0.01%
+9,206
New +$436K
ATEC icon
3232
Alphatec Holdings
ATEC
$1.44B
$421K ﹤0.01%
25,465
+23
+0.1% +$383
MRNS
3233
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$421K ﹤0.01%
9,092
+3,821
+72% +$143K
MRTX
3234
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$419K ﹤0.01%
13,341
+1,414
+12% +$41.7K
EML icon
3235
Eastern Company
EML
$150M
$418K ﹤0.01%
22,598
+1,700
+8% +$33.2K
APLP
3236
DELISTED
Archrock Partners, L.P. Common Units representing Limited Partner Interests
APLP
$418K ﹤0.01%
18,606
+162
+0.9% +$4.13K
LCNB icon
3237
LCNB Corp
LCNB
$283M
$415K ﹤0.01%
25,642
+11
+0% +$176
KIN
3238
DELISTED
Kindred Biosciences, Inc.
KIN
$413K ﹤0.01%
60,629
-7,252
-11% -$51.4K
DSGX icon
3239
Descartes Systems
DSGX
$6.82B
$411K ﹤0.01%
25,662
+1,466
+6% +$22.8K
CS
3240
DELISTED
Credit Suisse Group
CS
$411K ﹤0.01%
14,906
-8,534
-36% -$231K
EGLT
3241
DELISTED
Egalet Corporation
EGLT
$411K ﹤0.01%
28,547
-3,362
-11% -$36.9K
KING
3242
DELISTED
KING DIGITAL ENTMT PLC ORD SHS (IRL)
KING
$410K ﹤0.01%
+28,862
New +$447K
AXTI icon
3243
AXT Inc
AXTI
$5.8B
$409K ﹤0.01%
162,495
+132
+0.1% +$326
CBIO
3244
Crescent Biopharma
CBIO
$626M
$408K ﹤0.01%
513
+17
+3% +$14.1K
WBK
3245
DELISTED
Westpac Banking Corporation
WBK
$408K ﹤0.01%
16,496
-2,474
-13% -$67.3K
LNCO
3246
DELISTED
LINNCO LLC COM SHS REPSTG LTD LIABILITY
LNCO
$408K ﹤0.01%
43,194
+341
+0.8% +$3.81K
MNOV icon
3247
MediciNova
MNOV
$66M
$406K ﹤0.01%
102,797
+31,401
+44% +$124K
DARE icon
3248
Dare Bioscience
DARE
$21M
$405K ﹤0.01%
735
+409
+125% +$281K
GSIT icon
3249
GSI Technology
GSIT
$258M
$402K ﹤0.01%
77,181
+51
+0.1% +$270
SPNS
3250
DELISTED
Sapiens International
SPNS
$401K ﹤0.01%
38,676
+1,282
+3% +$11.6K

Similar funds

Geode Capital Management's Q2 2015 Portfolio in Review

As of Q2 2015, Geode Capital Management held 4,062 positions worth $175B, up 0.12% from $175B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Geode Capital Management's Q2 2015 filing shows 109 new, 2,831 increased, 660 reduced and 104 closed positions. Its largest new stake was Eversource Energy: 2,548,587 shares worth $116M. The largest sale was Allergan plc, an estimated $901M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.

  • Geode Capital Management's largest Q2 2015 buy was Eversource Energy: 2,548,587 shares worth $116M.
  • Geode Capital Management added most to Reynolds American Inc in Q2 2015, an estimated $61.4M increase.
  • Geode Capital Management's biggest Q2 2015 reduction was Apple, cutting an estimated $41.7M.
  • Geode Capital Management fully exited Allergan plc in Q2 2015, selling an estimated $901M.
  • Geode Capital Management's ten largest holdings make up 15% of its $175B portfolio in Q2 2015.
  • Geode Capital Management opened 109 new positions and closed 104 in Q2 2015.
  • Geode Capital Management's portfolio value rose 0.12% quarter-over-quarter to $175B.

Based on Geode Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.